Study S001322

EXEnatide in Patients Undergoing Coronary Artery Bypass Grafting for Improved glUcose conTrol and hemodynamIc ValuEs

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01373216
Acronym: Executive
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: SINGLE
Status: COMPLETED
Enrollment: 38
Start: 2011-06
Primary completion: 2014-05
Lead sponsor: Charles University, Czech Republic
Conditions: Coronary Artery Disease; Decreased Left Ventricular Function
Interventions: DRUG:Exenatide
Results posted: FALSE

Registered primary outcomes

Cardiac function - echocardiographic parameters [90 days after administration of exenatide]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0021691	Effect of continuous exenatide infusion on cardiac function and peri-operative glucose control in patients undergoing cardiac surgery: A single-blind, randomized controlled trial. Lipš M, Diabetes, obesity & metabolism	2017	Randomized trial	PMID 28581209 DOI	cites ClinicalTrials.gov:NCT01373216; registry reference DERIVED:28581209